Please Wait...

  • +91 22 2783 1455

  • Product background
    EPCRA-L (Rabeprazole (EC) & Levosulpiride (SR) Capsules)

WARNING: CAUTION : PLEASE NOTE :
The content or product detailing is not intended to replace advice from your prescribing doctor or healthcare professional. Lavina Pharma is not responsible for such actions by consumers. For any further information about the product please contact +91 22 2783 1455 and we can provide you the details.

EPCRA-L capsules is used for the treatment of Gastroesophageal Reflux Disease (GERD).

EPCRA-L is a combination of Rabeprazole (EC), a proton pump inhibitor that reduces stomach acid, and Levosulpiride (SR), a prokinetic agent that improves gastrointestinal motility.

It is used to treat GERD, acid reflux, and other digestive disorders. The enteric-coated and sustained-release formulation ensures prolonged action for extended relief.

It helps manage symptoms like heartburn, bloating, and indigestion. Side effects may include dizziness, headache, and diarrhea.


COMPOSITION

Each hard gelatin capsule contains:

Rabeprazole Sodium BP ………..20 mg

(As Enteric coated pellets)

Levosulpiride …………….75 mg

(As Sustained release pellets)

Approved colour used in hard gelatin capsule shells

 Oral

DOSAGE

As directed by the physician.

SIDE EFFECT

·         Headache

·         Diarrhoea, abdominal pain

·         Asthenia, flatulence

·         Rash & dry mouth

·         Acute muscular dystonia

·         Sedation or drowsiness





PRECAUTION

---




PRESENTATION

5 X 2 X 10 tablets.